-
Product Insights
NewMacrophage Stimulating Protein Receptor – Drugs In Development, 2024
The Macrophage Stimulating Protein Receptor pipeline drugs market research report outlays comprehensive information on the Macrophage Stimulating Protein Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Genetic Disorders which include indications of Breast Cancer, Pancreatic Cancer, and Neurofibromatoses Type I (Von Recklinghausen's Disease). It also reviews key players involved in Macrophage Stimulating Protein Receptor...
-
Product Insights
NewCoagulation Factor VIII – Drugs In Development, 2024
The Coagulation Factor VIII pipeline drugs market research report outlays comprehensive information on the Coagulation Factor VIII targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Hemophilia A (Factor VIII Deficiency), Von Willebrand Disease (vWD), Venous Thromboembolism, Acute Ischemic Stroke, Alzheimer's Disease, Amyotrophic Lateral Sclerosis,...
-
Product Insights
NewAlkaline Phosphatase – Drugs In Development, 2024
The Alkaline Phosphatase pipeline drugs market research report outlays comprehensive information on the Alkaline Phosphatase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genetic Disorders, Dermatology, Cardiovascular, and Gastrointestinal which include indications of Hypophosphatasia, Neurofibromatoses Type I (Von Recklinghausen's Disease), Burns, Pseudoxanthoma Elasticum (PXE or Gronblad Strandberg Syndrome), Atherosclerosis, Ischemia Reperfusion Injury, Ulcerative Colitis, and Celiac Disease....
-
Product Insights
NewMitogen Activated Protein Kinase 3 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase 3 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Genetic Disorders, and Cardiovascular which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Neurofibromatoses Type I (Von Recklinghausen's Disease), and Hypertension. It also reviews...
-
Product Insights
NewNeurofibromatoses Type I (Von Recklinghausen’s Disease) – Drugs In Development, 2024
Empower your strategies with our Neurofibromatoses Type I (Von Recklinghausen's Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Neurofibromatosis type 1 (NF1), also called von Recklinghausen's disease, is a rare genetic disorder characterized by the development of multiple noncancerous (benign) tumors of nerves and skin (neurofibromas). This is transmitted on chromosome 17 and is caused by mutation of the NF1 gene. Symptoms include liver enlargement, glioma, Lisch nodules, and pheochromocytoma. Treatment includes pain medications, surgery, chemotherapy,...
-
Product Insights
NewTyrosine Protein Kinase Lck – Drugs In Development, 2024
The Tyrosine Protein Kinase Lck pipeline drugs market research report outlays comprehensive information on the Tyrosine Protein Kinase Lck targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Oncology, Infectious Disease, and Genetic Disorders which include indications of Idiopathic Pulmonary Fibrosis, Interstitial Lung Fibrosis, Breast Cancer, Cervical Cancer, Influenzavirus A Infections, Coronavirus Disease 2019 (COVID-19) Pneumonia, Von...
-
Product Insights
NewCytotoxic T Lymphocyte Protein 4 – Drugs In Development, 2024
The Cytotoxic T Lymphocyte Protein 4 pipeline drugs market research report outlays comprehensive information on the Cytotoxic T Lymphocyte Protein 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Genetic Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Epstein–Barr Virus (HHV-4) Infections,...
-
Product Insights
NewEndothelial PAS Domain Containing Protein 1 – Drugs In Development, 2024
The Endothelial PAS Domain Containing Protein 1 pipeline drugs market research report outlays comprehensive information on the Endothelial PAS Domain Containing Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Genetic Disorders, and Undisclosed which include indications of Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Pulmonary Arterial Hypertension, Von Hippel-Lindau Syndrome, and Unspecified Rare...
-
Product Insights
NewDual Specificity Mitogen Activated Protein Kinase Kinase 1 – Drugs In Development, 2024
The Dual Specificity Mitogen Activated Protein Kinase Kinase 1 pipeline drugs market research report outlays comprehensive information on the Dual Specificity Mitogen Activated Protein Kinase Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Neurofibromatoses Type...
-
Product Insights
NewDual Specificity Mitogen Activated Protein Kinase Kinase 2 – Drugs In Development, 2024
The Dual Specificity Mitogen Activated Protein Kinase Kinase 2 pipeline drugs market research report outlays comprehensive information on the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Central Nervous System which include indications of Solid Tumor, Low-Grade Glioma, Neurofibromatoses Type I (Von...